Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 215750
Company: UMEDICA

Products on ANDA 215750

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 215750

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/11/2022	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 215750

DICLOFENAC POTASSIUM

TABLET;ORAL; 50MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
CATAFLAM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	076561	AMICI
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	215585	NOVAST LABS
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	075463	RK PHARMA
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	075229	RUBICON
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	215787	SENORES PHARMS
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	075219	TEVA
DICLOFENAC POTASSIUM	DICLOFENAC POTASSIUM	50MG	TABLET;ORAL	Prescription	No	AB	215750	UMEDICA